AZAINDOLE-2-CARBOXAMIDE DERIVATIVES

FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to compounds of formula (I) where R1 is chosen from a group consisting of phenyl, unsubstituted or substituted by one or two groups independently chosen from (lower) alkyl, (lower) phenylalkyl wherein a phenyl ring can be unsubstituted or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAJLOR SVEN, NETTEKOVEN MATTIAS, ROSHE OLIV'E, RIKHTER KHANS, PLANSHE ZHAN-MARK
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to compounds of formula (I) where R1 is chosen from a group consisting of phenyl, unsubstituted or substituted by one or two groups independently chosen from (lower) alkyl, (lower) phenylalkyl wherein a phenyl ring can be unsubstituted or substituted by one or two groups independently chosen from halogen; R2 represents hydrogen; or R1 and R2 together with nitrogen atom whereto attached, form a saturated 5- or 6-members heterocyclic ring optionally containing an additional oxygen heteroatom, said saturated heterocyclic ring is unsubstituted or substituted by one, two or three groups independently chosen from (lower) alkyl, halogen; R3 is chosen from a group consisting of hydrogen, (lower) alkyl, (lower) hydroxyalkyl, (lower) alkoxyalkyl, (lower) haloalkyl, (lower) cycloalkylalkyl, (lower) cyanoalkyl, (lower) alkylsulfonyl, phenyl unsubstituted or substituted by one or two groups independently chosen from halogen; R4 represents hydrogen or halogen; R5 represents a group chosen from where m represents 0 or 1; n represents 0,1 or 2; X represents CR13R13'; R6, R6', R7, R7', R8,R8', R13, R13' are independently chosen from a group consisting of hydrogen, (lower) alkyl, halogen; p represents 0 or 1; R9 is chosen from (lower) alkyl, cycloalkyl, (lower) cycloalkylalkyl; q represents 0 or 1; R10 represents (lower) alkyl; and to their pharmaceutically acceptable salts, as well as to a pharmaceutical composition exhibiting histamine 3 receptor antagonistic and/or antagonistic activity and based on the compounds of formula I. ^ EFFECT: there are prepared and described new compounds which can be effective in treatment and/or prevention of the diseases associated with H3 receptor modulation. ^ 24 cl, 34 ex Изобретение относится к соединениям формулы (I) ! ! где R1 выбран из группы, состоящей из фенила, незамещенного или замещенного одной или двумя группами, независимо выбранными из (низш.)алкила, (низш.)фенилалкила, в котором фенильное кольцо может быть незамещенным или замещенным одной или двумя группами, независимо выбранными из галогена; R2 представляет собой водород; или R1 и R2 вместе с атомом азота, к которому они присоединены, образуют насыщенное 5- или 6-членное гетероциклическое кольцо, необязательно содержащее дополнительный гетероатом кислорода, при этом упомянутое насыщенное гетероциклическое кольцо является незамещенным или замещенным одной, двумя или тремя группами, независимо выбранными из (низш.